HUTCHMED (China) HCM
NASDAQ HCM
$12.63 +0.07 (+0.56%)
At close: Aug 21, 2026 · 4:00 PM EDT

HUTCHMED (China) (HCM) Cash from Investing Activities (2018 - 2021)

HUTCHMED (China) (HCM) posted quarterly Cash from Investing Activities of -$315.9 million for Q2 2021, down 665.3% year-over-year from $55.9 million in Q2 2020, and down 297.41% quarter-over-quarter from $160.0 million in Q1 2021.

HUTCHMED (China) (HCM) Cash from Investing Activities (2018 - 2021) Analysis & Trends

HUTCHMED (China) (HCM) has reported Cash from Investing Activities for 4 consecutive years, with -$315.9 million the latest figure, recorded in Q2 2021.

  • In Q2 2021, Cash from Investing Activities fell 665.3% year-over-year to -$315.9 million; the TTM figure through Jun 2021 stood at -$295.0 million (down 281.98% YoY), while the FY2025 annual figure was -$3.8 million, up 69.28% from the prior year.
  • Cash from Investing Activities fell to -$315.9 million in Q2 2021 per HCM's latest filing, from $160.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $160.0 million in Q1 2021 and bottomed at -$315.9 million in Q2 2021.
  • Historically, Cash from Investing Activities has averaged -$11.0 million across 4 years, with a median of $19.0 million in 2019.
  • Annual changes were most pronounced in 2019 — Cash from Investing Activities surged 299.29% — and 2021, when it tumbled 665.3%.
  • HUTCHMED (China)'s Cash from Investing Activities stood at -$15.3 million in 2018, then jumped by 193.2% to $14.2 million in 2019, then slumped by 390.3% to -$41.3 million in 2020, then sank by 665.3% to -$315.9 million in 2021.
  • Business Quant data shows HCM's Cash from Investing Activities at -$315.9 million in Q2 2021, $160.0 million in Q1 2021, and -$41.3 million in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -491.00 Mn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -300.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -550.24 Mn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 87.50 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -51.60 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -135.40 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -110.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 HUTCHMED (China) 2.19 Bn 2.19 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2021 -315.92 Mn
Jun 30, 2021 -315.92 Mn
Mar 31, 2021 160.04 Mn
Mar 31, 2021 160.04 Mn
Jun 30, 2020 -41.28 Mn
Jun 30, 2020 -41.28 Mn
Mar 31, 2020 -97.84 Mn
Mar 31, 2020 -97.84 Mn
Dec 31, 2019 14.22 Mn
Dec 31, 2019 14.22 Mn
Sep 30, 2019 47.67 Mn
Sep 30, 2019 47.67 Mn
Jun 30, 2019 23.76 Mn
Jun 30, 2019 23.76 Mn
Mar 31, 2019 33.38 Mn
Mar 31, 2019 33.38 Mn
Dec 31, 2018 -15.26 Mn
Dec 31, 2018 -15.26 Mn
Sep 30, 2018 43.22 Mn
Sep 30, 2018 43.22 Mn